Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Rheumatology|May 4, 2005
Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseasesShunichi Kumagai, Seiji Kawano, Tatsuya Atsumi, et al.
Modern Rheumatology|November 17, 2016
Simplified Disease Activity Index remission at month 6 is an independent predictor of functional and structural remissions at month 12 during abatacept treatment in patients with rheumatoid arthritis: A multi-center, prospective cohort study in JapanHayato Yamazaki, Fumio Hirano, Tsutomu Takeuchi, et al.
Arthritis Research & Therapy|November 30, 2019
Risk stratification and clinical course of hepatitis B virus reactivation in rheumatoid arthritis patients with resolved infection: final report of a multicenter prospective observational study at Japanese Red Cross HospitalWataru Fukuda, Tadamasa Hanyu, Masaki Katayama, et al.
Annals of the Rheumatic Diseases|December 10, 2016
Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in JapanWataru Fukuda, Tadamasa Hanyu, Masaki Katayama, et al.
Modern Rheumatology|July 8, 2025
Vaccine-related environments and patient preferences in Japanese patients with autoimmune rheumatic diseasesKenji Oku, Hidehiro Yamada, Tatsuyoshi Ikenoue, et al.
Arthritis Research & Therapy|January 20, 2017
Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trialMasako Utsunomiya, Hiroaki Dobashi, Toshio Odani, et al.
The Journal of Rheumatology|February 3, 2015
Assessment of risks of pulmonary infection during 12 months following immunosuppressive treatment for active connective tissue diseases: a large-scale prospective cohort studyHayato Yamazaki, Ryoko Sakai, Ryuji Koike, et al.
Rheumatology Advances in Practice|November 2, 2020
An open-label, randomized controlled trial of sulfamethoxazole-trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-upMasako Utsunomiya, Hiroaki Dobashi, Toshio Odani, et al.
Modern Rheumatology|October 9, 2025
High Glucocorticoid Dependency and Limited Therapeutic Response in Japanese Patients with VEXAS Syndrome: A Multicentre Retrospective StudyAyaka Maeda, Yohei Kirino, Naomi Tsuchida, et al.
Annals of the Rheumatic Diseases|April 2, 2026
Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective studyYohei Kirino, Ayaka Maeda, Kana Higashitani, et al.
Pageof 3